Rocket Pharmaceuticals (RCKT) Return on Assets (2015 - 2026)

Rocket Pharmaceuticals (RCKT) has 11 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Assets slipped to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2025 to a low of 6.8% in Q1 2022.
• A 5-year average of 1.42% and a median of 0.01% in 2026 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 1144 bps in 2022, while the deepest fall reached 23 bps in 2022.
• Tracing RCKT's Return on Assets over 5 years: stood at 0.02% in 2022, then dropped by 25 bps to 0.02% in 2023, then surged by 73 bps to 0.01% in 2024, then tumbled by 61 bps to 0.01% in 2025, then decreased by 8 bps to 0.01% in 2026.
• Business Quant data shows RCKT's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.